Finance

Beta
Lists
DLB:NYSE
Dolby Laboratories Inc
$54.19
+0.76%
(+0.41) 1D
Jun 8, 3:22:36 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DLB...
Open
$53.59
High
$54.40
Low
$53.02
Mkt. cap
5.13B
Avg. vol.
873.34K
Volume
350.06K
Dividend
2.66%
Quarterly dividend
$0.36
Ex-dividend date
May 12, 2026
P/E ratio
21.43
52-wk high
$77.00
52-wk low
$52.45
EPS
$2.53
Beta
0.81
Shares outstanding
60.35M
No. of employees
2K
Open
$53.59
High
$54.40
Low
$53.02
Mkt. cap
5.13B
Avg. vol.
873.34K
Volume
350.06K
Dividend
2.66%
Quarterly dividend
$0.36
Ex-dividend date
May 12, 2026
P/E ratio
21.43
52-wk high
$77.00
52-wk low
$52.45
EPS
$2.53
Beta
0.81
Shares outstanding
60.35M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to DLB in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DLB in the last 3 months.
Highest
Current $54.19
$90.00 (+66.08%)
Average
$87.50 (+61.47%)
Lowest
$85.00 (+56.86%)
News stories
From sources across the web
Profile
Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television imaging. Dolby licenses its technologies to consumer electronics manufacturers. Wikipedia
About Dolby Laboratories Inc
CEOKevin J. Yeaman
Employees2.05K
FoundedMay 18, 1965
Headquarters-
SectorSoftware
Websitedolby.com
Last report
Apr 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.37 / $1.36
+0.74%beat
Revenue / Est. (USD)
395.63M / 390.52M
+1.31%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
315.55M
307.02M
346.71M
395.63M
Cost of goods sold
44.00M
39.52M
43.21M
44.73M
Cost of revenue
44.00M
39.52M
43.21M
44.73M
Research and development expenses
65.98M
67.46M
69.08M
63.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158.47M
164.24M
161.80M
172.12M
Operating expense
224.45M
231.70M
230.87M
235.77M
Total operating expenses
268.45M
271.22M
274.08M
280.50M
Operating income
47.09M
35.80M
72.63M
115.13M
Other non operating income
-133.00K
-1.22M
24.00K
-1.80M
EBT including unusual items
55.52M
41.67M
71.60M
119.70M
EBT excluding unusual items
54.97M
47.80M
82.07M
121.45M
Income tax expense
8.97M
-7.99M
17.92M
24.24M
Effective tax rate
16.16%
-19.17%
25.03%
20.25%
Other operating expenses
-
-
-
-
Net income
46.07M
49.33M
53.33M
94.92M
Net profit margin
14.60%
16.07%
15.38%
23.99%
Earnings per share
0.78
0.99
1.06
1.37
Interest and investment income
4.11M
5.06M
4.12M
5.02M
Interest expense
-
-
-
-
Net interest expenses
4.11M
5.06M
4.12M
5.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
69.02M
57.80M
96.77M
139.23M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more